G6PC2: A negative regulator of basal glucose-stimulated insulin secretion

Diabetes

Volumn 62, Issue 5, 2013, Pages 1547-1556

  Pound, Lynley D ^a   Oeser, James K ^a   O'Brien, Tracy P ^a   Wang, Yingda ^a   Faulman, Chandler J ^a   Dadi, Prasanna K ^a   Jacobson, David A ^a   Hutton, John C ^b   McGuinness, Owen P ^a   Shiota, Masakazu ^a   O'Brien, Richard M ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF COLORADO DENVER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; GLUCOSE; GLUCOSE 6 PHOSPHATASE; GLUCOSE 6 PHOSPHATASE C 2; INSULIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY COMPOSITION; CATALYSIS; CONTROLLED STUDY; CYTOPLASM; ENDOPLASMIC RETICULUM; ENZYME ACTIVITY; FEMALE; GENE DELETION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; GLYCOLYSIS; INSULIN BLOOD LEVEL; INSULIN RELEASE; INSULIN SENSITIVITY; LIPID DIET; MALE; MORTALITY; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL;

ADIPOSITY; ANIMALS; BLOOD GLUCOSE; CALCIUM SIGNALING; DIET, HIGH-FAT; FEMALE; GLUCOSE-6-PHOSPHATASE; HETEROZYGOTE; INSULIN; INSULIN RESISTANCE; INSULIN-SECRETING CELLS; ISLETS OF LANGERHANS; KINETICS; MALE; MICE; MICE, CONGENIC; MICE, KNOCKOUT; OBESITY; PANCREAS; PROTEINS; SEX CHARACTERISTICS;

EID: 84876525267     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db12-1067     Document Type: Article

References (41)

1. Abdul-Ghani MA, DeFronzo RA. Plasma glucose concentration and prediction of future risk of type 2 diabetes. Diabetes Care 2009;32(Suppl. 2):S194-S198
2. Khaw KT, Wareham N, Luben R, et al. Glycated haemoglobin, diabetes, and mortality in men in Norfolk cohort of european prospective investigation of cancer and nutrition (EPIC-Norfolk). BMJ 2001;322:15-18 (Pubitemid 32066250)
3. Lawes CM, Parag V, Bennett DA, et al.; Asia Pacific Cohort Studies Collaboration. Blood glucose and risk of cardiovascular disease in the Asia Pacific region. Diabetes Care 2004;27:2836-2842
4. Coutinho M, Gerstein HC, Wang Y, Yusuf S. The relationship between glucose and incident cardiovascular events. A metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years. Diabetes Care 1999;22:233-240 (Pubitemid 29056916)
5. DECODE Study Group, European Diabetes Epidemiology Group. Is the current definition for diabetes relevant to mortality risk from all causes and cardiovascular and noncardiovascular diseases? Diabetes Care 2003;26:688-696
6. Bouatia-Naji N, Rocheleau G, Van Lommel L, et al. A polymorphism within the G6PC2 gene is associated with fasting plasma glucose levels. Science 2008;320:1085-1088 (Pubitemid 351929551)
7. Chen WM, Erdos MR, Jackson AU, et al. Variations in the G6PC2/ABCB11 genomic region are associated with fasting glucose levels. J Clin Invest 2008;118:2620-2628 (Pubitemid 351949789)
8. Wang Y, Martin CC, Oeser JK, et al. Deletion of the gene encoding the isletspecific glucose-6-phosphatase catalytic subunit-related protein autoantigen results in a mild metabolic phenotype. Diabetologia 2007;50:774-778 (Pubitemid 46355820)
9. Hutton JC, O'Brien RM. Glucose-6-phosphatase catalytic subunit gene family. J Biol Chem 2009;284:29241-29245
10. Petrolonis AJ, Yang Q, Tummino PJ, et al. Enzymatic characterization of the pancreatic islet-specific glucose-6-phosphatase-related protein (IGRP). J Biol Chem 2004;279:13976-13983 (Pubitemid 38468931)
11. Ashcroft SJ, Randle PJ. Glucose-6-phosphatase activity of mouse pancreatic islets. Nature 1968;219:857-858
12. van Schaftingen E, Gerin I. The glucose-6-phosphatase system. Biochem J 2002;362:513-532 (Pubitemid 34242301)
13. Khan A, Chandramouli V, Ostenson CG, et al. Evidence for the presence of glucose cycling in pancreatic islets of the ob/ob mouse. J Biol Chem 1989;264:9732-9733 (Pubitemid 19159231)
14. Sweet IR, Najafi H, Li G, Grodberg J, Matschinsky FM. Measurement and modeling of glucose-6-phosphatase in pancreatic islets. Am J Physiol 1997;272:E696-E711
15. Matschinsky FM. Banting Lecture 1995. A lesson in metabolic regulation inspired by the glucokinase glucose sensor paradigm. Diabetes 1996;45:223-241 (Pubitemid 26045806)
16. Iynedjian PB. Molecular physiology of mammalian glucokinase. Cell Mol Life Sci 2009;66:27-42
17. Serreze DV, Chapman HD, Varnum DS, et al. B lymphocytes are essential for the initiation of T cell-mediated autoimmune diabetes: analysis of a new "speed congenic" stock of NOD.Ig mu null mice. J Exp Med 1996;184:2049-2053 (Pubitemid 26404497)
18. Bonnevie-Nielsen V, Steffes MW, Lernmark A. A major loss in islet mass and B-cell function precedes hyperglycemia in mice given multiple low doses of streptozotocin. Diabetes 1981;30:424-429 (Pubitemid 11022833)
19. Shiota C, Rocheleau JV, Shiota M, Piston DW, Magnuson MA. Impaired glucagon secretory responses in mice lacking the type 1 sulfonylurea receptor. Am J Physiol Endocrinol Metab 2005;289:E570-E577 (Pubitemid 41356077)
20. Pound LD, Sarkar SA, Ustione A, et al. The physiological effects of deleting the mouse SLC30A8 gene encoding zinc transporter-8 are influenced by gender and genetic background. PLoS One 2012;7:e40972
21. Morgan CR, Lazarow AL. Immunoassay of insulin: two antibody system: plasma insulin of normal, subdiabetic, and diabetic rats. Diabetes 1963;12:115-126
22. Jacobson DA, Weber CR, Bao S, Turk J, Philipson LH. Modulation of the pancreatic islet beta-cell-delayed recti fier potassium channel Kv2.1 by the polyunsaturated fatty acid arachidonate. J Biol Chem 2007;282:7442-7449 (Pubitemid 47093692)
23. Li X, Shu YH, Xiang AH, et al. Additive effects of genetic variation in GCK and G6PC2 on insulin secretion and fasting glucose. Diabetes 2009;58:2946-2953
24. Rose CS, Grarup N, Krarup NT, et al. A variant in the G6PC2/ABCB11 locus is associated with increased fasting plasma glucose, increased basal hepatic glucose production and increased insulin release after oral and intravenous glucose loads. Diabetologia 2009;52:2122-2129
25. Ingelsson E, Langenberg C, Hivert MF, et al.; MAGIC investigators. Detailed physiologic characterization reveals diverse mechanisms for novel genetic Loci regulating glucose and insulin metabolism in humans. Diabetes 2010;59:1266-1275
26. Heni M, Ketterer C, t'Hart LM, et al. The impact of genetic variation in the G6PC2 gene on insulin secretion depends on glycemia. J Clin Endocrinol Metab 2010;95:E479-E484
27. Young GS, Kirkland JB. Rat models of caloric intake and activity: relationships to animal physiology and human health. Appl Physiol Nutr Metab 2007;32:161-176
28. Bouatia-Naji N, Bonnefond A, Baerenwald DA, et al. Genetic and functional assessment of the role of the rs13431652-A and rs573225-A alleles in the G6PC2 promoter that are strongly associated with elevated fasting glucose levels. Diabetes 2010;59:2662-2671
29. Fridlyand LE, Ma L, Philipson LH. Adenine nucleotide regulation in pancreatic beta-cells: modeling of ATP/ADP-Ca2+ interactions. Am J Physiol Endocrinol Metab 2005;289:E839-E848 (Pubitemid 41504384)
30. Tal M, Wu YJ, Leiser M, et al. [Val12] HRAS downregulates GLUT2 in beta cells of transgenic mice without affecting glucose homeostasis. Proc Natl Acad Sci USA 1992;89:5744-5748
31. Wang H, Iynedjian PB. Modulation of glucose responsiveness of insulinoma beta-cells by graded overexpression of glucokinase. Proc Natl Acad Sci USA 1997;94:4372-4377 (Pubitemid 27194248)
32. Wang H, Iynedjian PB. Acute glucose intolerance in insulinoma cells with unbalanced overexpression of glucokinase. J Biol Chem 1997;272:25731-25736 (Pubitemid 27438892)
33. Efrat S, Leiser M, Wu YJ, et al. Ribozyme-mediated attenuation of pancreatic beta-cell glucokinase expression in transgenic mice results in impaired glucose-induced insulin secretion. Proc Natl Acad Sci USA 1994;91:2051-2055 (Pubitemid 24092040)
34. Shameli A, Yamanouchi J, Thiessen S, Santamaria P. Endoplasmic reticulum stress caused by overexpression of islet-specific glucose-6-phosphatase catalytic subunit-related protein in pancreatic Beta-cells. Rev Diabet Stud 2007;4:25-32 (Pubitemid 47450222)
35. Martin CC, Bischof LJ, Bergman B, et al. Cloning and characterization of the human and rat islet-specific glucose-6-phosphatase catalytic subunitrelated protein (IGRP) genes. J Biol Chem 2001;276:25197-25207
36. Arden SD, Zahn T, Steegers S, et al. Molecular cloning of a pancreatic isletspecific glucose-6-phosphatase catalytic subunit-related protein. Diabetes 1999;48:531-542 (Pubitemid 29106866)
37. Koza RA, Nikonova L, Hogan J, et al. Changes in gene expression foreshadow diet-induced obesity in genetically identical mice. PLoS Genet 2006;2:e81
38. Postic C, Shiota M, Niswender KD, et al. Dual roles for glucokinase in glucose homeostasis as determined by liver and pancreatic beta cell-specific gene knock-outs using Cre recombinase. J Biol Chem 1999;274:305-315 (Pubitemid 29035064)
39. Osbak KK, Colclough K, Saint-Martin C, et al. Update on mutations in glucokinase (GCK), which cause maturity-onset diabetes of the young, permanent neonatal diabetes, and hyperinsulinemic hypoglycemia. Hum Mutat 2009;30:1512-1526
40. Jensen MV, Joseph JW, Ronnebaum SM, Burgess SC, Sherry AD, Newgard CB. Metabolic cycling in control of glucose-stimulated insulin secretion. Am J Physiol Endocrinol Metab 2008;295:E1287-E1297
41. Chen SY, Pan CJ, Nandigama K, Mansfield BC, Ambudkar SV, Chou JY. The glucose-6-phosphate transporter is a phosphate-linked antiporter deficient in glycogen storage disease type Ib and Ic. FASEB J 2008;22:2206-2213 (Pubitemid 351948640)